199 related articles for article (PubMed ID: 20460152)
21. Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates.
Dalrymple A; Wild EJ; Joubert R; Sathasivam K; Björkqvist M; Petersén A; Jackson GS; Isaacs JD; Kristiansen M; Bates GP; Leavitt BR; Keir G; Ward M; Tabrizi SJ
J Proteome Res; 2007 Jul; 6(7):2833-40. PubMed ID: 17552550
[TBL] [Abstract][Full Text] [Related]
22. Metabolic characterization of the R6/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopy.
Tsang TM; Woodman B; McLoughlin GA; Griffin JL; Tabrizi SJ; Bates GP; Holmes E
J Proteome Res; 2006 Mar; 5(3):483-92. PubMed ID: 16512662
[TBL] [Abstract][Full Text] [Related]
23. Electrophoretic fractionation of creatine kinase isoenzymes and macroenzymes in clinically healthy dogs and cats and preliminary evaluation in central neurologic disease.
Paltrinieri S; Cazzaniga S; da Cunha NP; Giordano A
Vet Clin Pathol; 2010 Sep; 39(3):329-36. PubMed ID: 20698943
[TBL] [Abstract][Full Text] [Related]
24. Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease.
Dufour BD; McBride JL
Neurobiol Dis; 2019 Jan; 121():214-229. PubMed ID: 30292559
[TBL] [Abstract][Full Text] [Related]
25. Atrophy and degeneration in sciatic nerve of presymptomatic mice carrying the Huntington's disease mutation.
Wade A; Jacobs P; Morton AJ
Brain Res; 2008 Jan; 1188():61-8. PubMed ID: 18062944
[TBL] [Abstract][Full Text] [Related]
26. Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease.
Leoni V; Mariotti C; Tabrizi SJ; Valenza M; Wild EJ; Henley SM; Hobbs NZ; Mandelli ML; Grisoli M; Björkhem I; Cattaneo E; Di Donato S
Brain; 2008 Nov; 131(Pt 11):2851-9. PubMed ID: 18772220
[TBL] [Abstract][Full Text] [Related]
27. Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II/III in YAC72 and R6/2 transgenic mice partially model Huntington's disease patients.
Seo H; Kim W; Isacson O
Hum Mol Genet; 2008 Oct; 17(20):3144-53. PubMed ID: 18640989
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease.
Borovecki F; Lovrecic L; Zhou J; Jeong H; Then F; Rosas HD; Hersch SM; Hogarth P; Bouzou B; Jensen RV; Krainc D
Proc Natl Acad Sci U S A; 2005 Aug; 102(31):11023-8. PubMed ID: 16043692
[TBL] [Abstract][Full Text] [Related]
29. Circulating microRNAs in Huntington's disease: Emerging mediators in metabolic impairment.
Díez-Planelles C; Sánchez-Lozano P; Crespo MC; Gil-Zamorano J; Ribacoba R; González N; Suárez E; Martínez-Descals A; Martínez-Camblor P; Álvarez V; Martín-Hernández R; Huerta-Ruíz I; González-García I; Cosgaya JM; Visioli F; Dávalos A; Iglesias-Gutiérrez E; Tomás-Zapico C
Pharmacol Res; 2016 Jun; 108():102-110. PubMed ID: 27155059
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
Elife; 2021 Apr; 10():. PubMed ID: 33871358
[TBL] [Abstract][Full Text] [Related]
31. Role of Dynein Axonemal Heavy Chain 6 Gene Expression as a Possible Biomarker for Huntington's Disease: a Translational Study.
Areal LB; Pereira LP; Ribeiro FM; Olmo IG; Muniz MR; do Carmo Rodrigues M; Costa PF; Martins-Silva C; Ferguson SSG; Guimarães DAM; Pires RGW
J Mol Neurosci; 2017 Dec; 63(3-4):342-348. PubMed ID: 29019003
[TBL] [Abstract][Full Text] [Related]
32. Altered sensory experience exacerbates stable dendritic spine and synapse loss in a mouse model of Huntington's disease.
Murmu RP; Li W; Szepesi Z; Li JY
J Neurosci; 2015 Jan; 35(1):287-98. PubMed ID: 25568121
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotective effects of synaptic modulation in Huntington's disease R6/2 mice.
Stack EC; Dedeoglu A; Smith KM; Cormier K; Kubilus JK; Bogdanov M; Matson WR; Yang L; Jenkins BG; Luthi-Carter R; Kowall NW; Hersch SM; Beal MF; Ferrante RJ
J Neurosci; 2007 Nov; 27(47):12908-15. PubMed ID: 18032664
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of genes involved in metabolism and oxidative stress in the peripheral leukocytes of Huntington's disease patients.
Chang KH; Chen YC; Wu YR; Lee WF; Chen CM
PLoS One; 2012; 7(9):e46492. PubMed ID: 23029535
[TBL] [Abstract][Full Text] [Related]
35. Plasma neurofilament light in Huntington's disease: A marker for disease onset, but not symptom progression.
Parkin GM; Corey-Bloom J; Snell C; Castleton J; Thomas EA
Parkinsonism Relat Disord; 2021 Jun; 87():32-38. PubMed ID: 33940564
[TBL] [Abstract][Full Text] [Related]
36. Levels of Interleukin-6 in Saliva, but Not Plasma, Correlate with Clinical Metrics in Huntington's Disease Patients and Healthy Control Subjects.
Corey-Bloom J; Fischer RS; Kim A; Snell C; Parkin GM; Granger DA; Granger SW; Thomas EA
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887270
[TBL] [Abstract][Full Text] [Related]
37. Centrosome disorganization in fibroblast cultures derived from R6/2 Huntington's disease (HD) transgenic mice and HD patients.
Sathasivam K; Woodman B; Mahal A; Bertaux F; Wanker EE; Shima DT; Bates GP
Hum Mol Genet; 2001 Oct; 10(21):2425-35. PubMed ID: 11689489
[TBL] [Abstract][Full Text] [Related]
38. Progressive Cl- channel defects reveal disrupted skeletal muscle maturation in R6/2 Huntington's mice.
Miranda DR; Wong M; Romer SH; McKee C; Garza-Vasquez G; Medina AC; Bahn V; Steele AD; Talmadge RJ; Voss AA
J Gen Physiol; 2017 Jan; 149(1):55-74. PubMed ID: 27899419
[TBL] [Abstract][Full Text] [Related]
39. Liver function in Huntington's disease assessed by blood biochemical analyses in a clinical setting.
Nielsen SM; Vinther-Jensen T; Nielsen JE; Nørremølle A; Hasholt L; Hjermind LE; Josefsen K
J Neurol Sci; 2016 Mar; 362():326-32. PubMed ID: 26944172
[TBL] [Abstract][Full Text] [Related]
40. Exosomes as a potential messenger unit during heterochronic parabiosis for amelioration of Huntington's disease.
Lee M; Im W; Kim M
Neurobiol Dis; 2021 Jul; 155():105374. PubMed ID: 33940179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
